Sonic Incytes develops the VELACUR device, an AI-guided 3D S-WAVE ultrasound elastography system that measures liver stiffness and attenuation to assess fatty liver disease at the point of care. This technology provides real-time, non-invasive diagnostics with deeper measurements and larger tissue samples, enabling trained medical professionals to deliver accurate results without requiring extensive sonography experience.
Funding
$14.7M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
NSFounders
Product
Problem
Diagnosing and monitoring non-alcoholic fatty liver disease (NAFLD) and its more severe form, non-alcoholic steatohepatitis (NASH), often requires invasive biopsies or expensive imaging techniques that are not readily accessible at the point of care. Traditional ultrasound methods may lack the sensitivity and accuracy needed for early detection and reliable monitoring of disease progression.
Solution
Sonic Incytes offers VELACUR, an AI-guided 3D S-WAVE ultrasound elastography system designed for point-of-care assessment of fatty liver disease. VELACUR measures key indicators such as liver stiffness, attenuation, and Velacur Determined Fat Fraction (VDFF) using a non-invasive procedure. The system's 3D Shear Wave Absolute Vibro-Elastography (S-WAVE) technology enables deeper measurements and larger tissue sample volumes compared to traditional transient elastography. AI guidance ensures confident measurements, even for inexperienced operators or patients with high BMI. Real-time results facilitate immediate patient consultation and treatment planning during the same visit.
Target Audience
The primary target audience includes medical professionals such as hepatologists, gastroenterologists, primary care physicians, and endocrinologists who need a cost-effective and accurate point-of-care solution for assessing and managing fatty liver disease.
Features
- AI-guided user interface for simplified operation and consistent measurement acquisition
- 3D S-WAVE technology providing 2x the depth and 30x the volume of transient elastography
- Measures liver stiffness, attenuation, and VDFF for comprehensive liver assessment
- Single probe design suitable for a range of body types (BMI of 25 to 45) without requiring recalibration
- Real-time display of elasticity and attenuation measurements
- Lower upfront cost and higher reimbursement potential compared to transient elastography without imaging